Minimal: Personalized Weight Loss Solutions with Semaglutide At Minimal, we understand that the journey to shedding pounds can feel overwhelming
Whilst the market is currently led by Novo Nordisks semaglutide (Ozempic/Wegovy) and Eli Lillys tirzepatide (Mounjaro/Zepbound), stronger competition is expected with new entrants (Boehringer Ingelheim, Amgen, Pfizer, Roche amongst others) offering novel mechanisms (dual agonists, triple agonists and amylins), formulations (oral vs injectable) and dosing regimens (daily vs weekly vs monthly).
Alongside compounded semaglutide and tirzepatide, they prescribe Sermorelin for growth-hormone support, NAD+ for energy and cellular repair, and tadalafil for sexual-health support all under one online medical evaluation
doi: 10.1136/bmj.m1086 15 De FloraS.GrassiC.CaratiL
No potential mutagenicity of tesamorelin acetate was revealed in a battery of tests including induction of gene mutations in bacteria (the Ames test), gene mutations in mammalian cells grown in vitro (hamster CHOK1 cells), and chromosomal damage in intact animals (bone marrow cells in mice)